Methamphetamine-induced modification of dopamine metabolism in cultured striatal astrocytes

Pharmacology and Toxicology

Volumn 83, Issue 1, 1998, Pages 36-39

  Kita, Taizo ^a   Philbert, Martin A ^a   Wagner, George C ^a   Huang, Jian ^a   Lowndes, Herbert E ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CLORGYLINE; DOPAMINE; FREE RADICAL; METHAMPHETAMINE; MONOAMINE OXIDASE INHIBITOR; OXIDOPAMINE; PARGYLINE; SELEGILINE; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOOXIDATION; CONTROLLED STUDY; DOPAMINE METABOLISM; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

EID: 0031840349     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01439.x     Document Type: Article

References (22)

1. Cohen, G. & R. E. Heikkila: The generation of hydrogen peroxide, superoxide radical and hydroxy radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J. Biol. Chem. 1974, 249, 2447-2452.
2. Demarest, K. T., D. J. Smith & A. J. Azzarao: The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons. J. Pharmacol. Exp. Therap. 1980, 215, 461-168.
3. Evans, J. & G. Cohen: Catecholamine uptake inhibitors elevate 6-hydroxydopamine in brain after administration of 6-hydroxydopa, Eur. J. Pharmacol. 1993, 232, 241-245.
4. Gibb, J. W. & F. J. Kogan: Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 1979, 310, 185-187.
5. Halliwell, B. & J. M. C. Gutteridge: Free radical in biology and medicine. Clarendon Press, Oxford, London 1985.
6. Hazell, A. S., Y. Itzhak, H. Liu & M. D. Norenberg: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes. J. Neurochem. 1997, 68, 2216-2219.
7. Juorio, A. V., W. Walz & B. D. Soley: Absence of decarboxylation of some aromatic-L-amino acid by cultured astrocytes. Brain Res. 1987, 426, 183-186.
8. Karoum, F., S. J. Chrapusta, M. F. Egan & R. J. Wyatt: Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: A mass fragmentographic study. J. Neurochem. 1993, 61, 1369-1375.
9. Kimelberg, H. K., J. Tuula & W. Walz: Regulation of the brain microenviroment: Transmitters and Ions. In Astrocytes. Ed.: S. Murphy. Academic Press, New York 1993, pp. 3-228.
10. Kita, T., G. C. Wagner, M. A. Philbert, L. King & H. E. Lowndes: Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion. Mol. Chem. Neuropath. 1994, 24, 31-41.
11. Kostrzewa, R. & D. Jacobowiz: Effect of 6-hydroxydopa on peripheral adrenergic neurons. J. Pharmacol. Exp. Ther. 1972, 183, 284-297.
12. Levitt, P., J. E. Pintar & X. O. Breakfield: Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurones. Proc. Nat. Acad. Sci. 1982, 79, 6385-6389.
13. Ramon, L. & E. P. Bosch: Isolation of astrocytes and Schwann cells for culture. Meth. Neurosci., 1990, 2, 47-56.
14. Ricaurte, G. A., R. W. Guillery, L. S. Seiden, C. R. Schuster & R. Y. Moore: Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 1982, 235, 93-102.
15. Rollema, H., J. B. De Vries, B. H. C. Westerink, F. M. S. Van Putten & A. S. Horn: Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine. methylamphetamine, and MPTP, Eur. J. Pharmacol. 1986, 132, 65-69.
16. Schmued, L. C. & J. F. Bowyer: Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain. Res. 1997, 759, 135-140.
17. Seiden, L. S. & G. Vosmer: Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol. Biochem. Behav. 1984, 21, 29-31.
18. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. Mallia, F. Gartner, M. D. Provenzano, E. Fujimoto, N. Goeke, B. Olson & D. C. Klenk: Measurement of protein using bicinchoninic acid. Annl. Biochem. 1985, 150, 76-85.
19. Suzuki, O., H. Hattori, M. Asano, M. Oya & Y. Katsumata: Inhibition of monoamine oxidase by d-methamphetamine. Biochem. Pharmacol. 1980, 29, 2071-2073.
20. Wagner, G. C. L. S. Seiden & C. R. Schuster: Methamphetamine induced changes in brain catecholamines in rats and guinea pigs. Drug and Alcohol Dep. 1979, 4, 435-438.
21. Wagner, G. C., G. A. Ricaurte, L. S. Seiden, C. R. Schuster, R. J. Miller & J. Westley: Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 1980, 181, 151-160.
22. Wilson, J. M., K. S. Kalasinsky, A. I. Levey, C. Bergeron, G. Reiber, R. M. Anthony, G. A. Schmunk, K. Shannak, J. W. Haycock & S. J. Kish: Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med. 1996, 2, 699-703.